| Bioactivity | NNC63-0532 is a novel non-peptide nociceptin receptor (ORL1) agonist, with EC50s of 305?nM. NNC63-0532 plays important roles in many disorders such as pain, drug addiction[1]. | ||||||||||||
| Name | NNC 63-0532 | ||||||||||||
| CAS | 250685-44-0 | ||||||||||||
| Formula | C27H29N3O3 | ||||||||||||
| Molar Mass | 443.54 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. C Thomsen, et al. (8-Naphthalen-1-ylmethyl-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl)-acetic acid methyl ester (NNC 63-0532) is a novel potent nociceptin receptor agonist. Br J Pharmacol. 2000 Nov;131(5):903-8. |
NNC 63-0532
CAS: 250685-44-0 F: C27H29N3O3 W: 443.54
NNC63-0532 is a novel non-peptide nociceptin receptor (ORL1) agonist, with EC50s of 305?nM. NNC63-0532 plays important r
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.